Vanda Pharmaceuticals
VNDA • NASDAQ
Vanda Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mihael H. Polymeropoulos, with a market cap of $400.8M.
Market Cap$400.8M
Employees203.0
CEOMihael H. Polymeropoulos
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Vanda Pharmaceuticals FAQ
Common questions about Vanda Pharmaceuticals
Vanda Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $55.0M.
Vanda Pharmaceuticals has approximately 203 employees.